Literature DB >> 29599363

Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy.

Kyohei Abe1, Tadashi Uwagawa2, Koichiro Haruki2, Yuki Takano2, Shinji Onda2, Taro Sakamoto2, Takeshi Gocho2, Katsuhiko Yanaga2.   

Abstract

BACKGROUND/AIM: Omega-3 fatty acids may improve cancer cachexia, but only in patients with pancreatic and bile duct cancer. Patients with pancreatic cancer commonly suffer from exocrine pancreatic insufficiency, and the ingestion of digestive enzyme supplements may improve absorption. PATIENTS AND METHODS: Racol®, an enteral nutrient formulated with omega-3 fatty acids, was administered to patients with unresectable pancreatic and bile duct cancer. The skeletal muscle mass and blood test data were taken pre-administration and at 4 and 8 weeks after. Patients with pancreatic cancer were given the digestive enzyme supplement LipaCreon® from the fifth week after the start of administration.
RESULTS: In all 27 patients, skeletal muscle mass was significantly increased at both 4 and 8 weeks after the start of administration versus pre-administration (p=0.006, p=0.002, respectively).
CONCLUSION: Omega-3 fatty acid supplementation in patients with unresectable pancreatic and bile duct cancer may improve cancer cachexia. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Biliary-pancreatic cancer; cancer cachexia; omega-3 fatty acids

Mesh:

Substances:

Year:  2018        PMID: 29599363     DOI: 10.21873/anticanres.12485

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Plasma desacyl ghrelin-to-acyl ghrelin ratio is a predictor of postoperative complications and prognosis after pancreaticoduodenectomy.

Authors:  Takahiro Nishida; Hironobu Tsubouchi; Takeomi Hamada; Naoya Imamura; Masahide Hiyoshi; Koichi Yano; Kenji Kangawa; Masamitsu Nakazato; Atsushi Nanashima
Journal:  Oncol Lett       Date:  2019-09-06       Impact factor: 2.967

Review 2.  The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia.

Authors:  Mit Joshi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2022-03-07       Impact factor: 3.396

Review 3.  The Lifelong Health Support 10: a Japanese prescription for a long and healthy life.

Authors:  Ahmed Arafa; Yoshihiro Kokubo; Rena Kashima; Masayuki Teramoto; Yukie Sakai; Saya Nosaka; Youko M Nakao; Emi Watanabe
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

4.  Herbal Medicine: Friend or Foe?

Authors:  Roberta Bourgon
Journal:  J Adv Pract Oncol       Date:  2022-05-23

Review 5.  Pancreatic cancer cachexia: three dimensions of a complex syndrome.

Authors:  Maximilian Kordes; Lars Larsson; Lars Engstrand; J-Matthias Löhr
Journal:  Br J Cancer       Date:  2021-03-19       Impact factor: 7.640

Review 6.  Pancreatic Cancer Cachexia: The Role of Nutritional Interventions.

Authors:  Toni Mitchell; Lewis Clarke; Alexandra Goldberg; Karen S Bishop
Journal:  Healthcare (Basel)       Date:  2019-07-09

Review 7.  Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials.

Authors:  Nai-Jung Chiang; Li-Tzong Chen; Yan-Shen Shan; Chun-Nan Yeh; Ming-Huang Chen
Journal:  Biomolecules       Date:  2021-01-13

8.  Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: a case-control study.

Authors:  Kyohei Abe; Tadashi Uwagawa; Ryoga Hamura; Yoshihiro Shirai; Jungo Yasuda; Kenei Furukawa; Hironori Shiozaki; Shinji Onda; Takeshi Gocho; Toru Ikegami
Journal:  Med Oncol       Date:  2022-04-28       Impact factor: 3.738

Review 9.  N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence.

Authors:  Marnie Newell; Vera Mazurak; Lynne M Postovit; Catherine J Field
Journal:  Cancers (Basel)       Date:  2021-03-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.